The Daily Byte
Breaking
Welcome to The Daily Byte — real stories from across Pakistan.
Thursday, 12 November 2026 · Pakistan

The Daily Byte

Stories from Pakistan that deserve to be heard
Minor UK News

What Is the NHS 18-Week Target and How Is It Measured?

By The Daily Byte ·12 Nov 2026 ·9 min read
Busy NHS hospital corridor with staff in scrubs and a doctor holding his head

The NHS 18-week target is the promise that 92 per cent of patients should start consultant-led treatment within 18 weeks of being referred by their GP. It is one of the most quoted numbers in British healthcare — and one the NHS has not met for more than a decade. The standard was last achieved in September 2015, and the government has committed to restoring it by March 2029.

The target was back in the news on 12 November 2026, when the latest figures showed the NHS still treating about 65 per cent of patients within 18 weeks — the same level it reached when it hit an interim milestone of 65 per cent in March 2026. This explainer sets out what the 18-week target is, how the wait is measured, what the latest numbers show, and what happens if you wait longer than 18 weeks.

What is the 18-week target?

The target covers what the NHS calls referral-to-treatment, or RTT, pathways. It applies to consultant-led elective care — planned, non-emergency treatment such as a hip replacement, a cataract operation or a first appointment with a hospital specialist — in England. The NHS Constitution sets the standard: 92 per cent of patients on incomplete pathways should have been waiting no longer than 18 weeks.

The 92 per cent figure is not 100 per cent for a deliberate reason. Some patients choose to wait longer, for example to fit treatment around work or family, and some need more complex care that takes longer to arrange. The standard allows for that by setting the bar at 92 per cent rather than every patient.

The target was introduced to give patients a clear expectation: once your GP refers you to a hospital consultant, the clock starts, and the NHS should have started your treatment within about four and a half months. It does not cover everything the NHS does. Accident and emergency waits, cancer waiting times, GP appointments and mental health services all have their own separate standards.

How is the 18-week wait measured?

The wait is measured as a pathway, not as a single appointment. The clock starts when the hospital receives the GP's referral, and it stops when treatment starts — or when a clinician decides treatment is not needed, or the patient decides not to go ahead. The first hospital appointment is only one step along the way; diagnostic tests, scans and follow-up appointments all happen inside the same 18-week window.

NHS England publishes the figures every month, based on the number of pathways still open at the end of the month. These are called incomplete pathways. The headline percentage — the one quoted in the news — is the share of incomplete pathways that have been waiting 18 weeks or less. The waiting list figure is a count of pathways, not of people: one person can be on more than one pathway, for example if they are waiting for treatment on a knee and an eye at the same time.

The clock can be paused in some circumstances. If a patient asks to delay treatment — because they are on holiday, for example, or want to wait until after a family event — the wait can be adjusted so the hospital is not penalised for a delay the patient chose. But the hospital cannot pause the clock simply because it has no appointment available; that is the delay the target is designed to measure.

Where does the NHS stand now?

The government set an interim milestone of 65 per cent of patients waiting no longer than 18 weeks by March 2026. NHS England announced on 14 May 2026 that the milestone had been met, at 65.3 per cent, with the waiting list at 7.11 million pathways — its lowest level in three and a half years. The next milestones are 70 per cent by March 2027 and the full 92 per cent constitutional standard by March 2029.

Since March, however, progress has stalled. Figures published by NHS England show the waiting list at 7.33 million pathways in July 2026, with 65.3 per cent of cases waiting less than 18 weeks and a median wait of 12 weeks. In August the list rose to an estimated 7.37 million pathways, with about 65.2 per cent within 18 weeks. The number of individual patients on the list is lower than the pathway count — roughly 6.21 million people in July 2026.

MeasureFigureWhen
Patients waiting within 18 weeks58.8 per centJuly 2024
Patients waiting within 18 weeks65.3 per centMarch 2026 — interim milestone met
Patients waiting within 18 weeks65.3 per centJuly 2026
Patients waiting within 18 weeksAbout 65.2 per centAugust 2026
Waiting list (pathways)7.62 millionJuly 2024
Waiting list (pathways)7.33 millionJuly 2026
Waiting list (pathways)7.37 millionAugust 2026
Median wait12 weeksJuly 2026
Next milestone70 per centMarch 2027
Full constitutional standard92 per centMarch 2029

There has been real progress over two years: between July 2024 and July 2026 the list fell from 7.62 million to 7.33 million pathways, and the share of patients treated within 18 weeks rose from 58.8 per cent to 65.4 per cent. But the figures have barely moved since the spring, and the gap to the 2029 target remains wide.

Why has the NHS struggled to reach 92 per cent?

The main reason is demand. Referrals have been rising faster than the NHS can treat patients. The Health Foundation, an independent health think tank, reported in October 2026 that referrals had risen to 21.7 million a year, with growth doubling from 1.5 per cent in the government's first year to 3.0 per cent in its second. GPs are driving most of the increase.

The Health Foundation's analysis warned that on current trends the NHS would fall a long way short of the 2029 pledge. If referrals and removals from the waiting list continue to grow at their current pace, it projected that 92 per cent of patients would still be waiting up to 34.9 weeks by the end of the parliament — almost twice the 18-week standard. Meeting the pledge, it said, would require the growth in patients removed from the list to more than double, from the current rate of 2.2 per cent a year to more than 4.5 per cent a year.

Strikes have also taken a toll. NHS analysis cited in 2026 estimated that strike action in 2025/26 alone wiped out around 171,776 appointments and procedures. And the service is operating from a difficult starting point: the median wait is now 12 weeks, compared with 6.9 weeks in March 2019, before the pandemic, and the waiting list is still more than double its pre-Covid level of around 4.4 million pathways.

None of this means the target is unreachable. The NHS delivered 18.6 million treatments in the year to March 2026 — a record — and the government channelled £120 million in sprint funding into trusts in early 2026 with the single aim of hitting the 65 per cent milestone by March. The question now is whether that pace can be sustained and accelerated enough to reach 70 per cent by March 2027 and 92 per cent by March 2029.

What counts towards the target — and what does not

The 18-week standard covers consultant-led elective care in England only. It includes most planned hospital treatment: operations, procedures and first outpatient appointments with a consultant. It does not include emergency care, so a wait in A&E is measured against a different standard — the four-hour target for being admitted, transferred or discharged.

Cancer care is also measured separately. Patients with suspected cancer have their own waiting time standards, including a target to be seen within two weeks of an urgent GP referral and to start treatment within a set period after diagnosis. Those figures are published separately by NHS England and are not part of the 18-week RTT figures.

GP appointments are not covered either: the 18-week clock only starts once the GP has referred you. And the target applies to England. Scotland, Wales and Northern Ireland run their own health services and publish their own waiting time figures under different systems.

One figure that often causes confusion is the waiting list itself. When the news reports a waiting list of 7.37 million, that is a count of treatment pathways, not people. NHS England estimates the number of individual patients is roughly a million lower, because some patients are waiting for more than one treatment at the same time.

What happens if you wait longer than 18 weeks?

Under the NHS Constitution, patients have the right to start consultant-led treatment within 18 weeks of referral, or to be offered treatment by an alternative provider if that is not possible. In practice, if your wait is going beyond 18 weeks, you can contact the hospital's patient advice and liaison service, known as PALS, or your GP to ask about the position and whether treatment elsewhere is an option.

You can also check your position through the NHS App, which shows referral information, or through the NHS England My Planned Care website, which publishes average waiting times by hospital and specialty. Waiting times vary sharply by specialty and by hospital, so the national average of about 65 per cent within 18 weeks hides wide local differences: some trusts treat nearly all their patients within 18 weeks, while others manage far fewer.

If your condition gets worse while you are waiting, you should contact your GP, who can ask the hospital to bring your appointment forward or reassess the urgency of your case. The 18-week standard is a maximum for routine care; urgent cases are prioritised and seen sooner.

It is worth remembering that the 18-week figure is about the start of treatment, not the end of it. For many patients, treatment means an operation or a course of therapy that takes place over weeks or months after it begins. The target measures the wait to get started, not the full course of care.

Frequently asked questions

What is the NHS 18-week target? It is the standard, set out in the NHS Constitution, that 92 per cent of patients should start consultant-led treatment within 18 weeks of being referred by their GP. It applies to planned, non-emergency care in England.

When was the 18-week target last met? The 92 per cent standard was last met in September 2015. The NHS hit an interim milestone of 65 per cent of patients within 18 weeks in March 2026, and the government has committed to reaching 70 per cent by March 2027 and 92 per cent by March 2029.

How long are people actually waiting? In July 2026, 65.3 per cent of patients on the waiting list had been waiting less than 18 weeks, and the median wait was 12 weeks. The waiting list stood at 7.33 million treatment pathways, covering about 6.21 million individual patients.

Does the 18-week target cover A&E and cancer? No. A&E waits and cancer waits have their own separate standards. The 18-week target covers planned consultant-led treatment, such as operations and specialist appointments, after a GP referral.

What can I do if I have waited more than 18 weeks? You can contact the hospital's patient advice and liaison service (PALS) or your GP to ask about your position and whether treatment by another provider is possible. If your condition worsens while you wait, contact your GP so your case can be reassessed.

Sources: NHS England referral-to-treatment statistics; UK Parliament written answer, 18 December 2025; Health Foundation analysis, October 2026.